Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
about
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) familyADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural OverviewThe Function and Roles of ADAMTS-7 in Inflammatory DiseasesGenetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug TargetsStructure analysis reveals the flexibility of the ADAMTS-5 active siteStructural Basis for Activity Regulation and Substrate Preference of Clostridial Collagenases G, H, and TStructure of human ADAM-8 catalytic domain complexed with batimastatAllosteric activation of ADAMTS13 by von Willebrand factor.ADAMTS13 and von Willebrand factor interactions.The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.Molecular models of the Mojave rattlesnake (Crotalus scutulatus scutulatus) venom metalloproteinases reveal a structural basis for differences in hemorrhagic activitiesAnti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis.Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implicationsMechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2)A Novel Genome-Wide Association Study Approach Using Genotyping by Exome Sequencing Leads to the Identification of a Primary Open Angle Glaucoma Associated Inversion Disrupting ADAMTS17.A smallest 6 kda metalloprotease, mini-matrilysin, in living world: a revolutionary conserved zinc-dependent proteolytic domain- helix-loop-helix catalytic zinc binding domain (ZBD).Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases.Metabolic Response of Human Osteoarthritic Cartilage to Biochemically Characterized Collagen Hydrolysates.ADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4.A Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active OligomersLinker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity.Emerging Roles of ADAMTSs in Angiogenesis and Cancer.Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5.Production, crystallization and preliminary crystallographic analysis of an exosite-containing fragment of human von Willebrand factor-cleaving proteinase ADAMTS13.Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM functionUnusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease.Advances in the development of novel aggrecanase inhibitors.Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis.Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis.Pharmacophore development and screening for discovery of potential inhibitors of ADAMTS-4 for osteoarthritis therapy.The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.Molecular basis for the mechanism of action of an anti-TACE antibody.Design, synthesis, and preliminary biological evaluation of pyrrolo[3,4-c]quinolin-1-one and oxoisoindoline derivatives as aggrecanase inhibitors.Inhibitor of intramembrane protease RseP blocks the σ response causing lethal accumulation of unfolded outer membrane proteins
P2860
Q21146633-37078340-DD21-4BBE-AB4F-7FA459898D64Q26747656-449B901C-CE8F-4439-8907-3B9788709368Q26773190-041EAC3A-63CA-4603-9F21-DE5A2DDEE799Q26822238-0088AEB4-928E-4D18-B6C7-083536E5A794Q27667156-2B3FD199-CF7C-48F6-8BB0-CA387D4AD92BQ27678282-C4906469-22ED-4B3B-BC27-87A10DA60809Q27681067-BB9365C9-8896-4605-8DF3-EAEE20634057Q29568910-11DCB814-2F08-41BC-B5B6-12409A6C2486Q33424570-160D1FCC-A8DC-4F72-96B9-8957E14B6622Q33715032-F480406C-7A22-4393-A434-0F3214A8455FQ33726161-E0D01FFC-6E5E-401A-8856-E6AB8C368519Q33925651-D688FFE3-0A29-4FB9-A996-08DDA5EF0A00Q34196324-AE41AD12-E059-4B99-9900-98CD950648AAQ34205901-85081EFA-CA55-4DC9-9130-D8BBE5EDF21FQ34283551-36408F5F-45D5-4B30-A8B6-EBEF68FF050CQ34412131-65F5F2B2-EF3E-4E53-8B4A-5D44990F4221Q35105077-AC81D805-9E2D-48D0-9E29-12A7B9A608EFQ35754121-20B22342-0F56-4BA2-85CF-AEE2CBB7A81CQ35873120-53FB6F2B-1B80-4B91-A1CF-7916948C1063Q36123150-628C4E4A-88EE-4C42-99A6-50365BEAED5DQ36137447-3BFFD902-4B53-4BB6-AB3A-4E69AB74E934Q36258538-BD775D6A-693C-4400-9E19-1CC40BEAE457Q36502133-9D7ED897-D84B-42F6-AB71-CFDD96541526Q36573930-38F0BE54-C996-4A6F-AD31-79C637DDFAE3Q36652558-FDA135FB-48D8-4D56-A096-81788EF6D12DQ36843699-844585E4-D720-4B89-BBA0-B28ED1883B33Q37017089-9CFD75E9-0DF0-429D-A0A5-ACD0668D07E4Q37130548-98D8B49C-6166-4A32-81B6-4BDFC3582FB3Q37250107-E119CAC3-1990-45CC-9845-03FC9B88B83EQ37428907-5B559698-1CA0-4018-B90B-49B427010432Q37431248-D37B3CEB-2AD7-4A7B-A2EB-E30758EA5A51Q37630738-17109D0A-56C9-40EC-AB65-258470DD02DEQ37812599-8479CEAF-F861-4492-8EF4-824C96E14239Q37862381-AF9DCFBA-06CC-406D-85FC-7E5118E06A6AQ38261368-59B5CC05-1C78-4644-9CEB-B54D8F8A4DEAQ39612919-00B38030-075C-491A-8FC9-1047F2194F98Q39677665-BF48860F-9CE6-4AE5-9CE5-FCC86A68B2EFQ42056348-7B75C0B0-D420-4AF9-8C7E-F4DCBE5DBD0DQ43105023-8163E625-971B-4FE8-BA55-52CACD2BFE61Q57751882-42745DCA-3078-4489-A63D-11AB0526B2AA
P2860
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@ast
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@en
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@nl
type
label
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@ast
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@en
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@nl
prefLabel
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@ast
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@en
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@nl
P2093
P2860
P3181
P356
P1433
P1476
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
@en
P2093
Bethany Freeman
Christopher Corcoran
Edward R Lavallie
Erica L Reifenberg
Katy Georgiadis
Kristine Svenson
Lidia Mosyak
Lisa A Collins-Racie
Mark Stahl
P2860
P3181
P356
10.1110/PS.073287008
P407
P577
2008-01-01T00:00:00Z